Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Derivation of New ICM-stage hESCs

  • Post author:
  • Post published:May 12, 2026
  • Post category:

Recent studies in the derivation of rodent pluripotent epiblast stem cells and their molecular characterizations have provided strong evidence that the conventional human embryonic stem cells may represent a distinct,…

Continue ReadingDerivation of New ICM-stage hESCs

Derivation of New ICM-stage hESCs

  • Post author:
  • Post published:May 12, 2026
  • Post category:

Recent studies in the derivation of rodent pluripotent epiblast stem cells and their molecular characterizations have provided strong evidence that the conventional human embryonic stem cells may represent a distinct,…

Continue ReadingDerivation of New ICM-stage hESCs

Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines

  • Post author:
  • Post published:May 12, 2026
  • Post category:

The government has strict rules for producing cells that will be transplanted into patients. For example, these regulations discourage the use of animal products that could transmit diseases to humans.…

Continue ReadingOptimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines

Generation of Pluripotent Cell Lines from Human Embryos

  • Post author:
  • Post published:May 12, 2026
  • Post category:

Human embryonic stem cells (hESCs) hold significant promise for regenerative medicine. In this application our goal is to derive hESC lines from pre-implantation embryos to generate a source of low…

Continue ReadingGeneration of Pluripotent Cell Lines from Human Embryos

New Cell Lines for Huntington’s Disease

  • Post author:
  • Post published:May 12, 2026
  • Post category:

Huntington’s disease (HD) is a devastating neurodegenerative disease with a 1/10,000 disease risk that always leads to death. These numbers do not fully reflect the large societal and familial cost…

Continue ReadingNew Cell Lines for Huntington’s Disease

Mechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells

  • Post author:
  • Post published:May 12, 2026
  • Post category:

Human embryonic stem cells (hESCs) are capable of unlimited self-renewal, a process to reproduce self, and retain the ability to differentiate into all cell types in the body. Therefore, hESCs…

Continue ReadingMechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells

MEF2C-Directed Neurogenesis From Human Embryonic Stem Cells

  • Post author:
  • Post published:May 12, 2026
  • Post category:

Understanding differentiation of human embryonic stem cells (hESCs) provides insight into early human development and will help directing hESC differentiation for future cell-based therapies of Parkinson’s disease, stroke and other…

Continue ReadingMEF2C-Directed Neurogenesis From Human Embryonic Stem Cells

Constructing a fate map of the human embryo

  • Post author:
  • Post published:May 12, 2026
  • Post category:

The United States government does not fund research involving human embryos or cells that were grown from them after August 9, 2001. In addition, other restrictions have been imposed that…

Continue ReadingConstructing a fate map of the human embryo

The Dangers of Mitochondrial DNA Heteroplasmy in Stem Cells Created by Therapeutic Cloning

  • Post author:
  • Post published:May 12, 2026
  • Post category:

n therapeutic cloning, a patient’s cell is combined (fused) to an enucleated donated egg (oocyte) from an unrelated woman or from another animal. It is hoped that cellular factors in…

Continue ReadingThe Dangers of Mitochondrial DNA Heteroplasmy in Stem Cells Created by Therapeutic Cloning

Using Human Embryonic Stem Cells to Understand and to Develop New Therapies for Alzheimer’s Disease

  • Post author:
  • Post published:May 12, 2026
  • Post category:

Alzheimer’s Disease (AD) is a progressive incurable disease that robs people of their memory and ability to think and reason. It is emotionally, and sometimes financially devastating to families that…

Continue ReadingUsing Human Embryonic Stem Cells to Understand and to Develop New Therapies for Alzheimer’s Disease
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us